Lyell Immunopharma, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-03-20: Federal exemption Rule 506(b); Types of securities offered Equity; "Sale and issuance of Series C Preferred Stock (""Series C"") and the underlying shares of Common Stock issuable upon conversion of Series C."; Date of first sale 2020-03-05; Total offering amount $492,999,957.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2020-03-20 | Rule 506(b) | Equity; "Sale and issuance of Series C Preferred Stock (""Series C"") and the underlying shares of Common Stock issuable upon conversion of Series C." | 2020-03-05 | $492,999,957 | $492,999,957 | $0 | 10 |
|---|